Preoperative C-reactive protein/albumin ratio predicts outcome of surgical papillary renal cell carcinoma. 2019

Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology Nanjing University, Jiangsu, PR China.

Aim: To evaluate the prognostic values of some preoperative inflammation-based factors including C-reactive protein/albumin ratio (CRP/Alb) and platelet level in papillary renal cell carcinoma (PRCC). Materials & methods: A total of 108 PRCC patients underwent partial or radical nephrectomy were retrospectively analyzed. The prognostic values were determined with Kaplan-Meier analysis, univariate and multivariate COX regression models. Results: CRP/Alb and platelet level were both significantly associated with subtype, Fuhrman grade, tumor stage, lymph node invasion, perinephric fat extension, shorter overall survival (OS) and disease-free survival (all p < 0.01). Further, CRP/Alb was an independent prognostic factor for OS (hazard ratio: 9.64, 95% CI: 2.17-23.78; p = 0.003). Conclusion: Relatively higher CRP/Alb independently predicted poorer OS of surgical PRCC patients.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005260 Female Females

Related Publications

Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
March 2017, BMC cancer,
Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
January 2019, PloS one,
Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
January 2015, International journal of clinical and experimental pathology,
Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
September 2018, Zhonghua wai ke za zhi [Chinese journal of surgery],
Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
January 2020, In vivo (Athens, Greece),
Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
July 2017, Oncotarget,
Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
August 2022, Annals of surgical treatment and research,
Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
November 2020, Journal of surgical oncology,
Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
December 2020, Journal of surgical oncology,
Jie Gao, and Sezim Agizamhan, and Xiaozhi Zhao, and Bo Jiang, and Haixiang Qin, and Mengxia Chen, and Hongqian Guo
March 2021, BMC oral health,
Copied contents to your clipboard!